Prevalence of vitamin D deficiency in patients with sickle cell disease in Bahrain
Abstract
Background: Patients with sickle cell disease (SCD) had a low serum level of vitamin D. The magnitude of this observational finding is neither clear in patients in Bahrain, nor its impact on the disease process.
Aim: To assess the prevalence of vitamin D deficiency (VDD) in homozygous patients with SCD, and to evaluate the clinical and biochemical predictors of occurrence of VDD in such patients.
Methods: We evaluated the vitamin D status in 70 patients with confirmed diagnosis of SCD and compared them with an age matched control group. Serum level of vitamin D, parathormone (PTH), calcium, phosphate, alkaline phosphatase, haemoglobin (Hb), and uric acid were measured. Linear regression analysis was performed to assess the relation between PTH and vitamin D level. Multiple regression analysis was performed to assess the predictive value of gender, age (>18 years), body mass index (BMI), serum level of uric acid and estimated glomerular filtration rate (eGFR) for vitamin D deficiency in patients with SCD.
Results: The mean age of the study group was 28.85 ±7.21 years compared with the control of 29.91 ±4.3 years, p=0.23. There were 40 (57%) female SCD patients compared with 39 (55%) in the control. In patients with SCD, the serum level of vitamin D was sufficient, >50 nmol/L in 4 (5%) patients, insufficient > 27.5 - ?50 nmol/L in 21 (30%) patients, deficient >12.5 - ?27.5 nmol/L 35 (50%) and profoundly deficient ?12.5 nmol/L in 10(15%). In the control group those with sufficient level of vitamin D were 53 (75%), insufficient 21(30%) deficient of 10 (15%) and none with profound deficiency, respectively. The serum level of PTH in the SCD group compared with control group was 6.92 ±0.6 pmol/L vs. 4.13±0.34 p mol/L (p<0.001), the serum level of alkaline phosphatase was 190.7 ±78 U/L vs. 41.03 ±12.78 (p<0.001), respectively. In SCD patients compared with normal population had significantly lower eGFR of 67.3 ±7.8 vs. 92.5 ±63.94, Hb of 8.9 ±0.8 vs. 13.01 ±1.12 gm/dl and bpm of 19.5 ±2.4 vs. 24.04 ±2.86. The serum level of uric acid was significantly higher (p < 0.05). Patients with SCD had higher heart rate of 80 vs. 70 bpm (p<0.001). There was no significant difference between serum level of calcium or phosphate. Linear regression analysis showed inverse relation between VDD (<25 nmol/L) and PTH (r = - 0.34, P<0.001). Multiple regression analysis showed female gender and age >18 years as positive predictors of VDD in SCD with odds ratio for female gender of 2.2 (95% CI: 1.8-2.6, P <0.05) , BMI >24 of 1.2(95%CI:0.8-1.6,P=0.02 ) and hyperuercemia >400 mg/L 1.0 (95%CI:0.8-1.2,P<0.04) , low eGFR (<60) of 0.8(95%CI: 0.7-0.9,P<0.045) and , age (>18 years) was of no significant predictive value.
Conclusion: The risk of vitamin D deficiency among subjects with SCD-SS was 3.8 folds greater than control subjects; the prevalence of VDD in SCD was 95% and 25% in the control patients without SCD. On linear regression analysis, there is a significant inverse relation between serum levels of vitamin D and PTH in SCD patients. The female gender, BMI>24, hyperurecemia and low eGFR were positive predictor of VDD in patients with SCD.
About this article
References
Platt OS, Brambilla DJ, Rosse WF, Milner PF, Castro O, Steinberg MH, et al. Mortality in sickle cell disease. Life expectancy and risk factors for early death, The New England journal of medicine,330(23)(1994):1639-44.
Ingram VM. A case of sickle-cell anaemia: a commentary on 'Abnormal Human Haemoglobins. I. The Comparison of Normal Human and Sickle-Cell Haemoglobins by 'Fingerprinting" with II. The Chymotryptic Digestion of the Trypsin-resistant 'Core' of Haemoglobins A and S and III. The Chemical Difference Between Normal and Sickle Cell Haemoglobins,Biochimica et biophysica acta,1000,(1989)147-50.
Clarke GM, Higgins TN. Laboratory investigation of hemoglobinopathies and thalassemias: review and update. Clinical chemistry,46(2000),1284-90.
Charache S, Terrin ML, Moore RD, Dover GJ, Barton FB, Eckert SV, et al. Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia, The New England journal of medicine,332(20)(1995)1317-22.
Steinberg MH, Barton F, Castro O, Pegelow CH, Ballas SK, Kutlar A, et al. Effect of hydroxyurea on mortality and morbidity in adult sickle cell anemia: risks and benefits up to 9 years of treatment. JAMA : the journal of the American Medical Association, 289(13)(2003)1645-51.
View more references (16)
Buison AM, Kawchak DA, Schall J, Ohene-Frempong K, Stallings VA, Zemel BS. Low vitamin D status in children with sickle cell disease. The Journal of pediatrics,145(5)(2004)622-7.
Chapelon E, Garabedian M, Brousse V, Souberbielle JC, Bresson JL, de Montalembert M. Osteopenia and vitamin D deficiency in children with sickle cell disease, European journal of haematology,83(6)(2009)572-8.
Rovner AJ, Stallings VA, Kawchak DA, Schall JI, Ohene-Frempong K, Zemel BS. High risk of vitamin D deficiency in children with sickle cell disease,Journal of the American Dietetic Association,108(9)(2008)1512-6.
Weatherall DJ, Clegg JB. Inherited haemoglobin disorders: an increasing global health problem. Bulletin of the World Health Organization,79(8)(2001)704-12.
Jastaniah W. Epidemiology of sickle cell disease in Saudi Arabia. Annals of Saudi medicine, 31(3)(2011)289-93.
Golbahar J, Al-Saffar N, Altayab Diab D, Al-Othman S, Darwish A, Al-Kafaji G. Predictors of vitamin D deficiency and insufficiency in adult Bahrainis: a cross-sectional study, Public health nutrition.(3) (2013)1-7.
Holick MF. Vitamin D deficiency. The New England journal of medicine,357(3)(2007)266-81
Goodman BM, 3rd, Artz N, Radford B, Chen IA, Prevalence of vitamin D deficiency in adults with sickle cell disease. Journal of the National Medical Association, 102(4)(2010):332-5.
Arlet JB, Courbebaisse M, Chatellier G, Eladari D, Souberbielle JC, Friedlander G, et al. Relationship between vitamin D deficiency and bone fragility in sickle cell disease: a cohort study of 56 adults, Bone,52(1)(2013)206-11.
Rovner AJ, Stallings VA, Schall JI, Leonard MB, Zemel BS. Vitamin D insufficiency in children, adolescents, and young adults with cystic fibrosis despite routine oral supplementation, The American journal of clinical nutrition, 86(6)92007)1694-9.
Erkal MZ, Wilde J, Bilgin Y, Akinci A, Demir E, Bodeker RH, et al. High prevalence of vitamin D deficiency, secondary hyperparathyroidism and generalized bone pain in Turkish immigrants in Germany: identification of risk factors. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA,17(8)(2006)1133-40.
Boonen S, Aerssens J, Dequeker J. Age-related endocrine deficiencies and fractures of the proximal femur. II implications of vitamin D deficiency in the elderly. The Journal of endocrinology,149(1)(1996)13-7.
Rodan SB, Rodan GA, Simmons HA, Walenga RW, Feinstein MB, Raisz LG. Bone resorptive factor produced by osteosarcoma cells with osteoblastic features is PGE2. Biochemical and biophysical research communications,102(4)(1981)1358-65.
Cashman KD, Hill TR, Cotter AA, Boreham CA, Dubitzky W, Murray L, et al. Low vitamin D status adversely affects bone health parameters in adolescents, The American journal of clinical nutrition,87(4)(2008)1039-44.
McSheehy PM, Chambers TJ. Osteoblastic cells mediate osteoclastic responsiveness to parathyroid hormone, Endocrinology,118(2)(1986)824-8.
Saintonge S, Bang H, Gerber LM. Implications of a new definition of vitamin D deficiency in a multiracial us adolescent population: the National Health and Nutrition Examination Survey III. Pediatrics,123(3)(2009)797-803.